Bupivacaine kinetics during hyperthermia in rats.
B Bruguerolle, X Roucoules, L Attolini, A M Lorec
文献索引:Can. J. Anaesth. 41(3) , 253-6, (1994)
全文:HTML全文
摘要
The aim of this study was to document possible alterations of bupivacaine pharmacokinetic behaviour in rats during hyperthermia. Two groups of Wistar AF IO PS male rats (Group A = normothermic controls, Group B = hyperthermia-induced animals) received a single 20 mg.kg-1 ip dose of bupivacaine. Two other groups (Group C = normothermic controls without bupivacaine, Group D = hyperthermia-induced animals without bupivacaine) received, under the same experimental conditions, an equivalent volume of saline. Hyperthermia-induced animals (Groups B and D) were placed in a water-bath at 40 degrees C. Bupivacaine or saline were administered (Group B and D) four hours after the beginning of the experiment and blood samples were obtained by retro-orbital sinus puncture 0.25, 0.5, 1, 2, 4 and 8 hr after administration. Bupivacaine and its main metabolite, 2,6 desbutylbupivacaine (PPX) were assayed according to a gas liquid chromatographic method. The Cmax, Tmax, t1/2, Cl, Vd and AUC were determined according to a two compartment open model. Our data have demonstrated a decrease in clearance of bupivacaine (5.85 +/- 0.23 ml.hr-1 and 4.59 +/- 0.35 ml.hr-1 for groups A and B, respectively, P < 0.05, and, Tmax of PPX during hyperthermia (0.24 +/- 0.03 hr and 0.15 +/- 0.0 hr for Groups A and B, respectively, P < 0.05). In conclusion, hyperthermia induces a decrease in bupivacaine clearance in rats which may be of importance in clinical practice.
相关化合物
相关文献:
1995-05-01
[Can. J. Anaesth. 42(5 Pt 1) , 434-7, (1995)]
2011-09-01
[Br. J. Anaesth. 107(3) , 409-24, (2011)]
2003-07-01
[Electrophoresis 24(14) , 2340-7, (2003)]
1995-01-01
[Chirality 7(4) , 272-7, (1995)]
1998-11-01
[Electrophoresis 19(16-17) , 2997-3002, (1998)]